Cargando…
Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells
Duchenne muscular dystrophy (DMD) is the most common hereditary muscular dystrophy caused by mutation in dystrophin, and there is no curative therapy. Dystrophin is a protein which forms the dystrophin-associated glycoprotein complex (DGC) at the sarcolemma linking the muscle cytoskeleton to the ext...
Autores principales: | Shimizu-Motohashi, Yuko, Asakura, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927135/ https://www.ncbi.nlm.nih.gov/pubmed/24600399 http://dx.doi.org/10.3389/fphys.2014.00050 |
Ejemplares similares
-
Implications of notch signaling in duchenne muscular dystrophy
por: Den Hartog, Lily, et al.
Publicado: (2022) -
Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
por: Bez Batti Angulski, Addeli, et al.
Publicado: (2023) -
Satellite cell contribution to disease pathology in Duchenne muscular dystrophy
por: Kodippili, Kasun, et al.
Publicado: (2023) -
Functional muscle ischemia in Duchenne and Becker muscular dystrophy
por: Thomas, Gail D.
Publicado: (2013) -
Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy
por: Verma, Mayank, et al.
Publicado: (2019)